Literature DB >> 12641507

Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia.

N A Koloski1, N J Talley, S S Huskic, P M Boyce.   

Abstract

BACKGROUND: The drivers of conventional and, especially, alternative health care use for irritable bowel syndrome and functional dyspepsia are not clear. AIM: To determine the predictors of conventional and alternative health care use for irritable bowel syndrome and functional dyspepsia.
METHODS: Two hundred and seven subjects with irritable bowel syndrome or functional dyspepsia, identified from a previous population survey, were included in the study. Individuals with irritable bowel syndrome/functional dyspepsia were defined as consulters (n = 103) if they had visited their doctor for gastrointestinal symptoms more than once in the past year. Controls (n = 100) did not report having any abdominal pain. Subjects were given structured interviews to assess the Diagnostic and Statistical Manual - version IV (DSM-IV) and International Classification of Disorders - version 10 (ICD-10) psychiatric diagnosis for anxiety, depression, somatization or any psychiatric diagnosis, aspects of health care use and symptom factors.
RESULTS: About one-half (n = 103, 49.8%) of community subjects with irritable bowel syndrome/functional dyspepsia had sought conventional care for gastrointestinal symptoms in the past 12 months. Lifetime rates for alternative health care use for gastrointestinal symptoms were 20.8% (n = 43). Independent predictors of conventional health care use were more frequent abdominal pain, greater interference of gastrointestinal symptoms with work and activities and a greater satisfaction with the physician-patient relationship. Being female independently predicted alternative health care use.
CONCLUSIONS: Psychological morbidity did not predict conventional or alternative health care use for gastrointestinal symptoms. Other factors were more important.

Entities:  

Mesh:

Year:  2003        PMID: 12641507     DOI: 10.1046/j.1365-2036.2003.01498.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  32 in total

Review 1.  Meditation over medication for irritable bowel syndrome? On exercise and alternative treatments for irritable bowel syndrome.

Authors:  Fredrick Asare; Stine Störsrud; Magnus Simrén
Journal:  Curr Gastroenterol Rep       Date:  2012-08

Review 2.  ACG and CAG Clinical Guideline: Management of Dyspepsia.

Authors:  Paul Moayyedi; Brian E Lacy; Christopher N Andrews; Robert A Enns; Colin W Howden; Nimish Vakil
Journal:  Am J Gastroenterol       Date:  2017-06-20       Impact factor: 10.864

3.  Rational investigations in irritable bowel syndrome.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Frontline Gastroenterol       Date:  2019-06-06

Review 4.  New treatments for IBS.

Authors:  Magnus Halland; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-13       Impact factor: 46.802

Review 5.  Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches.

Authors:  Gerald Holtmann; Dietmar Schrenk; Ahmed Madisch; Hans D Allescher; Gudrun Ulrich-Merzenich; Fermin Mearin; Dominique Larrey; Peter Malfertheiner
Journal:  Dig Dis       Date:  2019-11-26       Impact factor: 2.404

6.  Uninvestigated dyspepsia in Latin America: a population-based study.

Authors:  Jorge A Olmos; Valeria Pogorelsky; Federico Tobal; Mariano Marcolongo; Graciela Salis; Roberto Higa; Juan Carlos Chiocca
Journal:  Dig Dis Sci       Date:  2006-10-06       Impact factor: 3.199

Review 7.  Dyspepsia and its overlap with irritable bowel syndrome.

Authors:  William M Outlaw; Kenneth L Koch
Journal:  Curr Gastroenterol Rep       Date:  2006-08

8.  Prevalence of functional gastrointestinal disorders among consecutive new patient referrals to a gastroenterology clinic.

Authors:  Uday N Shivaji; Alexander C Ford
Journal:  Frontline Gastroenterol       Date:  2014-01-21

9.  Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities?

Authors:  R S Choung; G R Locke; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2011-12-12       Impact factor: 3.598

10.  Upper gastrointestinal symptoms, psychosocial co-morbidity and health care seeking in general practice: population based case control study.

Authors:  Linda E Bröker; Gerard J B Hurenkamp; Gerben ter Riet; François G Schellevis; Hans G Grundmeijer; Henk C van Weert
Journal:  BMC Fam Pract       Date:  2009-09-09       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.